Schedule 13G ownership disclosure

MARINUS PHARMACEUTICALS INC

Common Stock · CUSIP: 56854Q200

Event date: 2024-12-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Beryl Capital Management LLC

    Shares: 5,462,942.00 · Class: 9.9%

  • Beryl Capital Management LP

    Shares: 5,462,942.00 · Class: 9.9%

  • Beryl Capital Partners II LP

    Shares: 4,801,329.00 · Class: 8.7%

  • David A. Witkin

    Shares: 5,462,942.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000032
Form type
SCHEDULE 13G
Filer
Beryl Capital Management LLC
CIK
CIK 1719307
Filed
Jan 07, 2025
Reporting period
Dec 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub